In collaboration with York University, HYGEIA Group was proud to sponsor an exciting webinar on 28-Jan-2026 on the topic of Clinical Endpoints in Oncology featuring Dr. Ashwin Patel, a renowned clinical trialist with experience in developing clinical trial protocols for various immuno oncology (IO) assets including bi-specifics and ADC’s. Dr. Patel is the VP of Clinical Development at 92 Bio.
The webinar was hosted as part of the course, “Advanced Concepts in Pharmaceutical Drug Development” in York University’s Clinical Research Program. We are grateful to Dr. Patel for sharing his expertise and walking our students through the various challenges of structuring protocols including the use of PFS vs. OS as primary clinical endpoints and the nuances of using RECIST vs. iRECIST in measuring tumor progression for solid and liquid tumours.
A full recording of the webinar can be found here. Link to Webinar.